Home  »  Business   »  Take A Look At This Imago BioSciences Inc. (NASDAQ...

Take A Look At This Imago BioSciences Inc. (NASDAQ: IMGO) Analysis Before You Invest

Imago BioSciences Inc. (NASDAQ:IMGO) traded at $35.60 at last check on Tuesday, November 22, made an upward move of 0.03% on its previous day’s price.

Looking at the stock we see that its previous close was $35.59 with the day’s price range being $35.44 – $35.75. In terms of its 52-week price range, IMGO has a high of $35.75 and a low of $11.56. The company’s stock has gained about 133.99% over that past 30 days.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Imago BioSciences Inc. has a market cap of $1.25 billion. Estimates by analysts give the company expected earnings per share (EPS) of -$0.45, with the EPS growth for the year raised at -$1.84 for 2022 and -$2.44 for next year. These figures represent 31.90% and -32.60% growth in EPS for the two years respectively.

There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the IMGO stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 50% Buy.

Based on estimates by 6 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 3 have rated the Imago BioSciences Inc. (IMGO) stock as a Hold, while 3 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Overweight and investors could take advantage and scoop up stock of the company.

Looking further, we note the current price level is 99.05% off its SMA20 and 115.72% from its 50-day simple moving average. The RSI (14) is pointing at 88.66 while the volatility over the past week is 5.63% and jumps to 6.90% over the past one month. The average price target for the stock over the next 12 months is $35.50, with the estimates having a low of $35.00 and a high of $36.00. These price ends are 1.69% and -1.12% off the today’s price level respectively, although investors could be excited at the prospect of a 0.28% if the IMGO share price touches on the median price of $35.50.

Coming back to Imago BioSciences Inc. (NASDAQ:IMGO), we note that the average 3-month trading volume was 434.49K, while that of the preceding 10-day period stands at 2.23 million. Current shares outstanding are 33.77 million.

The insiders hold 1.50% of the company’s shares while institutions hold 95.70%. The data shows that short shares as of Oct 13, 2022, stood at 3.54 million at a short ratio of 27.65. This represents a 10.48% short interest in shares outstanding on Oct 13, 2022. Shares short rose in October from the previous month at 3.44 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 50.11% up in year-to-date price movement.

Leave a Comment

Your email address will not be published. Required fields are marked *